ESPERION THERAPEUTICS INC NE's ticker is ESPR and the CUSIP is 29664W105. A total of 109 filers reported holding ESPERION THERAPEUTICS INC NE in Q1 2016. The put-call ratio across all filers is 0.37 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $361,000 | +30.3% | 5,000 | +19.0% | 0.11% | +29.4% |
| Q4 2017 | $277,000 | -81.9% | 4,200 | -86.3% | 0.08% | -76.5% |
| Q3 2017 | $1,533,000 | -64.8% | 30,600 | -67.5% | 0.36% | -63.7% |
| Q2 2017 | $4,356,000 | -65.6% | 94,118 | -73.7% | 0.99% | +29.4% |
| Q1 2017 | $12,658,000 | +20996.7% | 358,493 | +7316.1% | 0.77% | +38300.0% |
| Q4 2016 | $60,000 | +172.7% | 4,834 | +202.1% | 0.00% | +100.0% |
| Q3 2016 | $22,000 | +633.3% | 1,600 | +433.3% | 0.00% | – |
| Q2 2016 | $3,000 | -97.9% | 300 | -96.4% | 0.00% | -100.0% |
| Q1 2016 | $141,000 | +182.0% | 8,300 | +267.1% | 0.01% | +266.7% |
| Q4 2015 | $50,000 | +316.7% | 2,261 | +352.2% | 0.00% | +200.0% |
| Q3 2015 | $12,000 | – | 500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Meditor Group Ltd | 2,629,835 | $116,685,000 | 25.08% |
| Aviva Holdings Ltd. | 1,200,100 | $53,248,000 | 14.21% |
| Boxer Capital, LLC | 1,375,000 | $61,009,000 | 6.77% |
| BB BIOTECH AG | 3,282,964 | $145,665,000 | 3.86% |
| Rhenman & Partners Asset Management AB | 353,961 | $15,705,000 | 1.57% |
| PFM Health Sciences, LP | 1,970,134 | $87,415,000 | 1.28% |
| Bellevue Group AG | 391,852 | $17,386,000 | 1.10% |
| Pentwater Capital Management LP | 2,351,500 | $104,336,000 | 0.88% |
| Partner Investment Management, L.P. | 25,440 | $1,129,000 | 0.86% |
| SABBY MANAGEMENT, LLC | 100,369 | $4,453,000 | 0.57% |